BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37261506)

  • 1. Histological and immunohistochemical prognostic factors of primary angiosarcoma.
    Ichiki T; Yamada Y; Ito T; Nakahara T; Nakashima Y; Nakamura M; Yoshizumi T; Shiose A; Akashi K; Oda Y
    Virchows Arch; 2023 Jul; 483(1):59-69. PubMed ID: 37261506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
    Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
    J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
    Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
    Jour G; Gullet A; Liu M; Hoch BL
    Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.
    Cornejo KM; Hutchinson L; Cyr MS; Nose V; McLaughlin PJ; Iafrate AJ; Sadow PM
    Endocr Pathol; 2015 Dec; 26(4):334-41. PubMed ID: 26223194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
    Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
    J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Primary Angiosarcoma: A Clinicopathologic and Imaging Study of a Series Cases.
    Darre T; Djiwa T; N'Timon B; Simgban P; Tchaou M; Napo-Koura G
    Breast Cancer (Auckl); 2022; 16():11782234221086726. PubMed ID: 35370408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.
    Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC
    Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiosarcoma of the visceral organs: A morphological, immunohistochemical, and C-MYC status analysis.
    Zhang J; Gong H; Wang Y; Zhang G; Hou P
    Pathol Res Pract; 2022 Oct; 238():154118. PubMed ID: 36087414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
    Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
    Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
    Shon W; Jenkins SM; Ross DT; Seitz RS; Beck RA; Ring BZ; Okuno SH; Gibson LE; Folpe AL
    J Cutan Pathol; 2011 Dec; 38(12):961-6. PubMed ID: 22050093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenic Mesenchymal Tumor: A Clinicopathologic and Molecular Study of 55 Cases of a Distinctive Neoplasm Originating From Mediastinal Yolk Sac Tumor and an Occasional Precursor to Angiosarcoma.
    Levy DR; Agaram NP; Kao CS; Franks SE; Kesler KA; Stram AR; Einhorn LH; Bangs CD; Ulbright TM
    Am J Surg Pathol; 2021 Apr; 45(4):463-476. PubMed ID: 33136584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal abnormalities and p53 gene mutation in a cardiac angiosarcoma.
    Zu Y; Perle MA; Yan Z; Liu J; Kumar A; Waisman J
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):24-8. PubMed ID: 11277410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.